Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ashok Kumar Kanugula"'
Autor:
Asim Kichloo, Michael Aljadah, Farah Wani, Michael Albosta, Jagmeet Singh, Zain El-Amir, Kirk Dettloff, Raja Chandra Chakinala, Ashok Kumar Kanugula, Shantanu Solanki, Savneek Chugh
Publikováno v:
Family Medicine and Community Health, Vol 8, Iss 3 (2020)
A narrative review was conducted to examine the current state of the utilisation of telemedicine amid the current COVID-19 pandemic and to evaluate the benefits of continuing telemedicine usage in the future. A literature review was performed for art
Externí odkaz:
https://doaj.org/article/56112ad1ace14ec18750d418032c286c
Publikováno v:
Cureus.
Autor:
Murtaza Hussain, Smit Deliwala, Mamoon M Elbedawi, Ashok Kumar Kanugula, Anoosha Ponnapalli, Ghassan Bachuwa, Viraj Modi
Publikováno v:
European Journal of Case Reports in Internal Medicine (2020)
Eur J Case Rep Intern Med
Eur J Case Rep Intern Med
Acute pancreatitis (AP) remains one of the most common causes of emergency department visits in the USA. The literature supports an association between angiotensin-converting enzyme inhibitors (ACEi), mainly at steady-state doses, and AP([1]). We pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d683ea95e9a61c4ade08b07ceae75a
https://www.ejcrim.com/index.php/EJCRIM/article/view/1956
https://www.ejcrim.com/index.php/EJCRIM/article/view/1956
Autor:
Ashok Kumar Kanugula, Jagmeet P. Singh, Asim Kichloo, Shantanu Solanki, Raja Chandra Chakinala, Farah Wani, Zain El-Amir, Michael Albosta, Savneek Chugh, Kirk Dettloff, Michael Aljadah
Publikováno v:
Family Medicine and Community Health
A narrative review was conducted to examine the current state of the utilisation of telemedicine amid the current COVID-19 pandemic and to evaluate the benefits of continuing telemedicine usage in the future. A literature review was performed for art
Publikováno v:
Cureus
Biological monoclonal antibodies such as infliximab have significantly remodeled inflammatory bowel disease's treatment course. Despite multiple side effects reported with infliximab, this medication has shown to be robust and practical. There is a p
Meta-analysis of optimal timing of coronary intervention in non-ST-elevation acute coronary syndrome
Autor:
Ashok Kumar Kanugula, Mohammad Luay Alkotob, Tarek Haykal, Owais Barbarawi, Deepak L. Bhatt, Yazan Zayed, Ghassan Bachuwa, Babikir Kheiri, Adam Chahine, Mahmoud Barbarawi
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventionsREFERENCES. 95(2)
We conducted a meta-analysis of randomized controlled trials (RCTs) to compare the efficacy and safety of early versus delayed invasive management of non-ST-elevation acute coronary syndrome (NSTE-ACS).Coronary angiography is recommended for patients
Autor:
Swathi Gorle, Shima Sidahmed, UyoyoTonte Omaduvie, Ghassan Bachuwa, Areeg Bala, Trailokya Nath Pandit, Eduard Drizik, Tarek Haykal, Sowmya Goranta, Khalil Katato, Ashok Kumar Kanugula
Publikováno v:
Journal of Clinical Oncology. 38:523-523
523 Background: The Oncotype-DX recurrence score (RS) allows providers to identify hormone receptor positive and HER2-negative breast cancer (BC) patients that may benefit from adjuvant chemotherapy (AC). The TAILORx Trial showed no benefit of AC amo